Entropy Neurodynamics Limited
ENP
Rang în acțiuni
#26196
Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical... Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical company, dedicated to pioneering novel formulations for psilocin administration. These formulations are intended for use alongside psychotherapy, aiming to tackle medical conditions with pressing unmet needs across Australia, Canada, Switzerland, and the United States. The firm's flagship development is TRP-8803, an intravenously infused psilocin formulation that has successfully concluded Phase 2 clinical trials. These trials investigated its potential to treat binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. Additionally, the company is advancing TRP-8802, a synthetic, orally administered psilocybin compound. TRP-8802 is currently undergoing Phase 2a clinical trials for binge eating and is in Phase 2 clinical development for fibromyalgia and irritable bowel syndrome. Established in 2019 and headquartered in Camberwell, Australia, the company adopted its current name, Entropy Neurodynamics Limited, in November 2025, having previously operated as Tryptamine Therapeutics Limited.
Preț acțiune
$0.02468497
Ultima sincronizare: 2026-07-30
Capitalizare de piață
$40.28M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-56.08%
Țară
AU
Tranzacționează Entropy Neurodynamics Limited (ENP)
Categorie
Healthcare
Capitalizarea de piață a Entropy Neurodynamics Limited(ENP)
Capitalizare de piață: $40.28M
În anul October 2026, Entropy Neurodynamics Limited are o capitalizare de piață de $40.28M. Acest lucru face ca Entropy Neurodynamics Limited să fie a 26196th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Entropy Neurodynamics Limited din 2021 până în 2026
ENP în comparație cu top 5 cele mai populare stocks
